178 related articles for article (PubMed ID: 8426203)
1. Second malignant neoplasms in children treated for rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee.
Heyn R; Haeberlen V; Newton WA; Ragab AH; Raney RB; Tefft M; Wharam M; Ensign LG; Maurer HM
J Clin Oncol; 1993 Feb; 11(2):262-70. PubMed ID: 8426203
[TBL] [Abstract][Full Text] [Related]
2. Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma.
Scaradavou A; Heller G; Sklar CA; Ren L; Ghavimi F
Cancer; 1995 Nov; 76(10):1860-7. PubMed ID: 8625059
[TBL] [Abstract][Full Text] [Related]
3. The Intergroup Rhabdomyosarcoma Study-II.
Maurer HM; Gehan EA; Beltangady M; Crist W; Dickman PS; Donaldson SS; Fryer C; Hammond D; Hays DM; Herrmann J
Cancer; 1993 Mar; 71(5):1904-22. PubMed ID: 8448756
[TBL] [Abstract][Full Text] [Related]
4. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
Crist WM; Anderson JR; Meza JL; Fryer C; Raney RB; Ruymann FB; Breneman J; Qualman SJ; Wiener E; Wharam M; Lobe T; Webber B; Maurer HM; Donaldson SS
J Clin Oncol; 2001 Jun; 19(12):3091-102. PubMed ID: 11408506
[TBL] [Abstract][Full Text] [Related]
5. Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group.
Raney RB; Asmar L; Vassilopoulou-Sellin R; Klein MJ; Donaldson SS; Green J; Heyn R; Wharam M; Glicksman AS; Gehan EA; Anderson J; Maurer HM
Med Pediatr Oncol; 1999 Oct; 33(4):362-71. PubMed ID: 10491544
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report.
Heyn R; Khan F; Ensign LG; Donaldson SS; Ruymann F; Smith MA; Vietti T; Maurer HM
Med Pediatr Oncol; 1994; 23(2):99-106. PubMed ID: 8202048
[TBL] [Abstract][Full Text] [Related]
7. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
8. Late effects of therapy in patients with paratesticular rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee.
Heyn R; Raney RB; Hays DM; Tefft M; Gehan E; Webber B; Maurer HM
J Clin Oncol; 1992 Apr; 10(4):614-23. PubMed ID: 1548524
[TBL] [Abstract][Full Text] [Related]
9. Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood.
Kony SJ; de Vathaire F; Chompret A; Shamsaldim A; Grimaud E; Raquin MA; Oberlin O; Brugières L; Feunteun J; Eschwège F; Chavaudra J; Lemerle J; Bonaïti-Pellié C
Lancet; 1997 Jul; 350(9071):91-5. PubMed ID: 9228960
[TBL] [Abstract][Full Text] [Related]
10. Second malignant neoplasms in children after treatment of soft tissue sarcoma.
Rich DC; Corpron CA; Smith MB; Black CT; Lally KP; Andrassy RJ
J Pediatr Surg; 1997 Feb; 32(2):369-72. PubMed ID: 9044156
[TBL] [Abstract][Full Text] [Related]
11. Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control study.
Guérin S; Guibout C; Shamsaldin A; Dondon MG; Diallo I; Hawkins M; Oberlin O; Hartmann O; Michon J; Le Deley MC; de Vathaire F
Int J Cancer; 2007 Jan; 120(1):96-102. PubMed ID: 17013899
[TBL] [Abstract][Full Text] [Related]
12. An Increased Risk of Second Malignant Neoplasms After Rhabdomyosarcoma: Population-Based Evidence for a Cancer Predisposition Syndrome?
Archer NM; Amorim RP; Naves R; Hettmer S; Diller LR; Ribeiro KB; Rodriguez-Galindo C
Pediatr Blood Cancer; 2016 Feb; 63(2):196-201. PubMed ID: 26193998
[TBL] [Abstract][Full Text] [Related]
13. Secondary malignant neoplasms following radiotherapy for primary cancer in children and young adults.
Harbron RW; Feltbower RG; Glaser A; Lilley J; Pearce MS
Pediatr Hematol Oncol; 2014 Apr; 31(3):259-67. PubMed ID: 24087931
[TBL] [Abstract][Full Text] [Related]
14. Local therapy is critical in localised pelvic rhabdomyosarcoma: experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee.
Réguerre Y; Martelli H; Rey A; Rogers T; Gaze M; Ben Arush MW; Devalck C; Oberlin O; Stevens M; Orbach D
Eur J Cancer; 2012 Sep; 48(13):2020-7. PubMed ID: 22154650
[TBL] [Abstract][Full Text] [Related]
15. Improved outcome for patients with middle ear rhabdomyosarcoma: a children's oncology group study.
Hawkins DS; Anderson JR; Paidas CN; Wharam MD; Qualman SJ; Pappo AS; Scott Baker K; Crist WM
J Clin Oncol; 2001 Jun; 19(12):3073-9. PubMed ID: 11408504
[TBL] [Abstract][Full Text] [Related]
16. Colorectal adenocarcinoma as a second malignant neoplasm following rhabdomyosarcoma of the urinary bladder: a case report.
Park SS; Kim BK; Kim CJ; Kim WS; Kim IO; Park KW; Shin HY; Ahn HS
J Korean Med Sci; 2000 Aug; 15(4):475-7. PubMed ID: 10983702
[TBL] [Abstract][Full Text] [Related]
17. Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group.
Breslow NE; Takashima JR; Whitton JA; Moksness J; D'Angio GJ; Green DM
J Clin Oncol; 1995 Aug; 13(8):1851-9. PubMed ID: 7636528
[TBL] [Abstract][Full Text] [Related]
18. Secondary neoplasms after radiotherapy for a childhood solid tumor.
Paulino AC; Fowler BZ
Pediatr Hematol Oncol; 2005 Mar; 22(2):89-101. PubMed ID: 15804994
[TBL] [Abstract][Full Text] [Related]
19. Soft tissue sarcoma as a second malignant neoplasm in the pediatric age group.
Bisogno G; Sotti G; Nowicki Y; Ferrari A; Garaventa A; Zanetti I; Favre C; Schiavetti A; Tamaro P; Carli M
Cancer; 2004 Apr; 100(8):1758-65. PubMed ID: 15073867
[TBL] [Abstract][Full Text] [Related]
20. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
Wolden SL; Anderson JR; Crist WM; Breneman JC; Wharam MD; Wiener ES; Qualman SJ; Donaldson SS
J Clin Oncol; 1999 Nov; 17(11):3468-75. PubMed ID: 10550144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]